Transition at Fonterra

2.6.26 Fonterra Co-operative Group’s Chief Innovation and Brand Officer, Komal Mistry-Mehta, has decided to leave the Co-op in October 2026, concluding a 15-year career with the business. Fonterra CEO Richard Allen acknowledged her significant contribution to...

Heartland & TSB plan merger

2.6.26 Increased scale is the objective of a merger of NZX-listed Heartland Bank and TSB Bank sprung on the market when NZX opened this morning. Heartland Group Holdings (NZX/ASX: HGH) has signed a conditional merger implementation agreement (MIA) with Toi Foundation...

New Synlait Milk director

  Synlait Milk announced that Katherine Turner has been appointed as an Independent Director. She has more than 25 years’ experience in executive and governance roles across the manufacturing, FMCG, agritech and primary sectors. Ms Turner has held leadership...

Rakon to delist next week

Rakon Ltd will be delisting from the NZX Main Board. The final day of trading in RAK ordinary shares will be Monday, 25 May with trading in RAK being halted and suspended at close of business. Subject to final NZX conditions being met, RAK ordinary shares will be...

AFT Pharmaceuticals names CFO

18.5.26 AFT Pharmaceuticals New Zealand’s largest domestic pharmaceuticals company, advised that Stuart Houliston will commence as Chief Financial Officer on June 15 2026. As advised in March, Malcolm Tubby will retire from the role on 29.5.26 and Simon Bosley will...

NZX appoint acting CEO

NZX has appointed Graham Law as the Acting Chief Executive of NZX. Chair John McMahon says with Mark Peterson leaving his role as NZX Chief Executive on 30 April, Law, NZX’s Chief Financial and Corporate Officer, will become Acting Chief Executive from 1 May. “Graham...